Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Guetens

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 20, 2004
Combretastatin A-4 phosphate enhances CPT-11 activity independently of the administration sequenceH Wildiers, B Ahmed, G Guetens, et al.
Cancer Chemotherapy and Pharmacology|October 1, 2010
Difluorodeoxyuridine plasma concentrations after low-dose gemcitabine during chemoradiation in head and neck cancer patientsP Specenier, G Guetens, J Dyck, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|February 5, 2003
Variations in flow, duration, and concentration do not change the final lung concentration of melphalan after isolated lung perfusion in ratsS Romijn, J M H Hendriks, B P Van Putte, et al.
British Journal of Cancer|June 12, 2003
Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11H Wildiers, G Guetens, G De Boeck, et al.
Seminars in Oncology|June 8, 2001
Erythrocytes and the transfer of anticancer drugs and metabolites: a possible relationship with therapeutic outcomeH Dumez, M Highley, G Guetens, et al.
Journal of Chromatography. A|July 26, 2005
Sensitive and specific quantification of the anticancer agent ZD1839 (Gefitinib) in plasma by on-column focusing capillary liquid chromatography-tandem mass spectrometryG Guetens, H Prenen, G De Boeck, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 9, 2005
Balloon catheter hypoxic pelvic perfusion with mitomycin C and melphalan for locally advanced tumours in the pelvic region: a phase I-II trialM G A van Ijken, B van Etten, G Guetens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2006
A phase I dose-finding clinical pharmacokinetic study of an oral formulation of irinotecan (CPT-11) administered for 5 days every 3 weeks in patients with advanced solid tumoursH Dumez, A Awada, M Piccart, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|April 1, 2000
Nanotechnology in bio/clinical analysisG Guetens, K Van Cauwenberghe, G De Boeck, et al.
Journal of Chromatography. A|December 5, 2002
Hyphenated techniques in anticancer drug monitoring. II. Liquid chromatography-mass spectrometry and capillary electrophoresis-mass spectrometryG Guetens, G De Boeck, M S Highley, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
European Journal of Cancer (Oxford, England : 1990)|January 20, 2004
Combretastatin A-4 phosphate enhances CPT-11 activity independently of the administration sequenceH Wildiers, B Ahmed, G Guetens, et al.
Cancer Chemotherapy and Pharmacology|October 1, 2010
Difluorodeoxyuridine plasma concentrations after low-dose gemcitabine during chemoradiation in head and neck cancer patientsP Specenier, G Guetens, J Dyck, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|February 5, 2003
Variations in flow, duration, and concentration do not change the final lung concentration of melphalan after isolated lung perfusion in ratsS Romijn, J M H Hendriks, B P Van Putte, et al.
British Journal of Cancer|June 12, 2003
Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11H Wildiers, G Guetens, G De Boeck, et al.
Seminars in Oncology|June 8, 2001
Erythrocytes and the transfer of anticancer drugs and metabolites: a possible relationship with therapeutic outcomeH Dumez, M Highley, G Guetens, et al.
Journal of Chromatography. A|July 26, 2005
Sensitive and specific quantification of the anticancer agent ZD1839 (Gefitinib) in plasma by on-column focusing capillary liquid chromatography-tandem mass spectrometryG Guetens, H Prenen, G De Boeck, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 9, 2005
Balloon catheter hypoxic pelvic perfusion with mitomycin C and melphalan for locally advanced tumours in the pelvic region: a phase I-II trialM G A van Ijken, B van Etten, G Guetens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2006
A phase I dose-finding clinical pharmacokinetic study of an oral formulation of irinotecan (CPT-11) administered for 5 days every 3 weeks in patients with advanced solid tumoursH Dumez, A Awada, M Piccart, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|April 1, 2000
Nanotechnology in bio/clinical analysisG Guetens, K Van Cauwenberghe, G De Boeck, et al.
Journal of Chromatography. A|December 5, 2002
Hyphenated techniques in anticancer drug monitoring. II. Liquid chromatography-mass spectrometry and capillary electrophoresis-mass spectrometryG Guetens, G De Boeck, M S Highley, et al.
Pageof 2